Connect with us
Information

WORLD EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

WORLD EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

nyse:abbv

POPULAR ARTICLES

Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis

life science investing

Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis

AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®

life science investing

AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®

VIDEO - Marc Lichtenfeld: Short or Long Term, Know Why You’re in Gold

VIDEO - Marc Lichtenfeld: Short or Long Term, Know Why You’re in Gold

LATEST ARTICLES

AbbVie’s VENCLEXTA Gets Health Canada Approval to Treat CLL

AbbVie to Acquire Allergan in Blockbuster US$63 Billion Deal

pharmaceutical investing

AbbVie to Acquire Allergan in Blockbuster US$63 Billion Deal

Pharma Market Update: Q1 2019 in Review

pharmaceutical investing

Pharma Market Update: Q1 2019 in Review

NYSE:ABBV

Which Life Science IPOs is the Government Shutdown Affecting?

NASDAQ:AMGN

Abbvie’s Humira Faces Biosimilar Competition

NYSE:ABBV

AbbVie Notches FDA Approval for Endometriosis Pain Treatment

Latest News

Premier American Uranium to Acquire Nuclear Fuels, Creating One of America's Largest Pure-Play Uranium Explorers

Hempalta Announces Participation in the 2025 Canadian Climate Investor Conference

Scoping Study Demonstrates Low Cost Potential (Replacement)

Victoria Gold-Silver Exploration Update

Scoping Study Demonstrates Low Cost ISR Uranium Potential